Almitas Capital LLC Alx Oncology Holdings Inc Transaction History
Almitas Capital LLC
- $177 Million
- Q1 2025
A detailed history of Almitas Capital LLC transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Almitas Capital LLC holds 1,353,141 shares of ALXO stock, worth $649,507. This represents 0.47% of its overall portfolio holdings.
Number of Shares
1,353,141
Previous 1,222,945
10.65%
Holding current value
$649,507
Previous $2.04 Million
58.96%
% of portfolio
0.47%
Previous 0.99%
Shares
2 transactions
Others Institutions Holding ALXO
# of Institutions
92Shares Held
35.4MCall Options Held
34KPut Options Held
36.9K-
Ven Bio Partners LLC San Francisco, CA9.7MShares$4.66 Million6.44% of portfolio
-
Redmile Group, LLC San Francisco, CA3.64MShares$1.75 Million0.24% of portfolio
-
Tang Capital Management LLC San Diego, CA3.16MShares$1.52 Million0.13% of portfolio
-
Black Rock Inc. New York, NY2.69MShares$1.29 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.84MShares$882,2030.0% of portfolio
About ALX ONCOLOGY HOLDINGS INC
- Ticker ALXO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,747,100
- Market Cap $19.6M
- Description
- ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...